News and Announcements

Faran S.A. & Novartis (Hellas) S.A. 

Faran S.A. and Novartis (Hellas) S.A. are pleased to announce the beginning of their collaboration in the field of therapeutic oncology. More specifically, in the context of its cooperation with Novartis, Faran undertakes the promotion and distribution in the Greek market of its formulations Novartis TYVERB (Lapatinib) and ZYKADIA (Ceritinib). TYVERB (Lapatinib) is indicated for […..]

Read More »